| Biogen Inc. | 220.0600 / -2.46% |
| Date/Time | 10/18 / 21:59 |
| Chg. / Chg.(%) | -5.5400 / -2.46% |
| Bid | 220.3900 / 800 |
| Ask | 221.0000 / 100 |
| Open | 225.4900 |
| Previous Close | 225.6000 |
| High | 225.4900 |
| Low | 220.0100 |
| Volume [USD] | 242,889,832.6010 |
| Volume [Units] | 2,802,068 |
| Price fixings | 10693 |
| ISIN | US09062X1037 |
| Security | BIIB |
| Exchange | NASDAQ |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 220.0600 |  |
2,802,068 |
| Cboe US | 220.05 | |
161,000 |
| IEX | 220.02 | |
56,792 |
| TradeGate | 197.900 | |
3,401 |
| Mexico | 4,239.00 | |
1,652 |
| London Inter.. | 221.50 | |
1,413 |
| Frankfurt | 198.7000 | |
513 |
| Xetra | 200.35 | |
218 |
| Stuttgart | 198.420 | |
84 |
| Vienna Globa.. | 200.60 | |
0 |
| München | 200.40 | |
0 |
| Hamburg | 200.40 | |
0 |
| Düsseldorf | 200.55 | |
0 |
| Berlin | 198.28 | |
0 |
| Hannover | 200.40 | |
0 |
| SIX Swiss Ex.. | 232.00 |  |
|
| Lang & Schwa.. | 196.900 | |
|
| gettex | 198.340 | |
News
- Global RNA-Targeted Small Molecules Study, 2019: A Landscape Analysis of Companies, Technologies, Targets, Investors, and Partners from an Industry Perspective
10/16/2019 / 13:51 - GlobeNewswire - Tcr² Therapeutics Appoints Industry Veteran Angela Justice, Ph.D., as Chief People Officer
10/09/2019 / 12:30 - GlobeNewswire - Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its Board
10/02/2019 / 14:20 - GlobeNewswire - Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA® (nusinersen) Published in Neuromuscular Disorders
10/02/2019 / 13:30 - GlobeNewswire - Apple Tree Partners Names Michael Ehlers as Chief Scientific Officer and Venture Partner
10/01/2019 / 14:10 - GlobeNewswire
Real-time